@article{75be2559c3124d85bd8f2b8cd008cc3a,
title = "ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancer",
abstract = "Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide, due in part to the propensity of lung cancer to metastasize. Aberrant epithelial-to-mesenchymal transition (EMT) is a proposed model for the initiation of metastasis. During EMT cell-cell adhesion is reduced allowing cells to dissociate and invade. Of the EMT-associated transcription factors, ZEB1 uniquely promotes NSCLC disease progression. Here we apply two independent screens, BioID and an Epigenome shRNA dropout screen, to define ZEB1 interactors that are critical to metastatic NSCLC. We identify the NuRD complex as a ZEB1 co-repressor and the Rab22 GTPase-activating protein TBC1D2b as a ZEB1/NuRD complex target. We find that TBC1D2b suppresses E-cadherin internalization, thus hindering cancer cell invasion and metastasis.",
author = "Roxsan Manshouri and Etienne Coyaud and Kundu, {Samrat T.} and Peng, {David H.} and Stratton, {Sabrina A.} and Kendra Alton and Rakhee Bajaj and Fradette, {Jared J.} and Rosalba Minelli and Peoples, {Michael D.} and Alessandro Carugo and Fengju Chen and Christopher Bristow and Kovacs, {Jeffrey J.} and Barton, {Michelle C.} and Tim Heffernan and Creighton, {Chad J.} and Brian Raught and Gibbons, {Don L.}",
note = "Funding Information: This work was supported by the NIH R37 CA214609-01A1, CPRIT-MIRA RP160652-P3, and Rexanna{\textquoteright}s Foundation for Fighting Lung Cancer to D.L.G., CPRIT multi-investigator award RP120713 C2 (C.J.C.) and NIH grant P30 CA125123 (C.J.C.). R.M. was supported by the Ruth L. Kirschstein National Research Service Award Individual Pre-doctoral Fellowship to Promote Diversity in Health-Related Research (NCI F31 CA232403-01) and Dr. John J. Kopchick Fellowship. D.P. was supported by a CPRIT Graduate Scholar Training Grant (RP140106). D.L.G. is an R. Lee Clark Fellow of the University of Texas MD Anderson Cancer Center, supported by the Jeane F Shelby Scholarship Fund. Work in the BR lab was supported by the Canada Foundation for Innovation and The Princess Margaret Cancer Foundation. The work was also supported by the generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shots Program. We would like to thank Dr. Andrew Gladden for providing critical feedback and reagents, Laura Gibson for technical assistance and the UTMDACC Department of Veterinary Medicine Facility. Publisher Copyright: {\textcopyright} 2019, The Author(s).",
year = "2019",
month = dec,
day = "1",
doi = "10.1038/s41467-019-12832-z",
language = "English (US)",
volume = "10",
journal = "Nature communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",
}